Insider txns (12m)
39
Stock / equity
PTHS Pelthos Therapeutics Inc.
- Company
- Pelthos Therapeutics Inc.
- Security
- Equity
- Size, estimated from filings
- Micro cap (under $300M)
- Insiders on record
- 8
- Latest trade on record
- October 2, 2026
PTHS (Pelthos Therapeutics Inc.) has 39 disclosed insider transactions from 8 insiders in the last 12 months (2 open-market buys, 26 sales, about $1.5M at reported prices) and 0 congressional trades from 0 members of Congress. The most recent disclosure was filed October 6, 2026.
Open-market buys / sales
2 / 26
Congress trades (12m)
0
Distinct filers (12m)
8
Share price
Price and chart by TradingView for Pelthos Therapeutics Inc.. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.
PTHS in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
BoughtSold
6 people account for the disclosed buying and selling in PTHS over the last 12 months; the most active is Davis Todd C with $1000K.
Prices insiders traded at
What price did insiders buy and sell at? Each marker is one open-market trade at the share price reported on its Form 4.
▲ Bought▼ SoldAverage reported price that day
Insiders reported 26 open-market trades in PTHS since Nov 25, 2025, at prices from $20.51 to $28.73; the most recent was a sale at $21.17 on Oct 2, 2026. These are the prices on the filings, not adjusted for stock splits, and not a market price series.
Insider holdings over time
Is an insider building or unwinding a position? Shares held directly after each filing.
Friedberg Ezra MPauls Matthew
Friedberg Ezra M reported 80,484 shares held after the latest filing, against 30,000 at the first on record.
Insiders trading PTHS
Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns.
| Insider | Role | Rows | Bought | Sold | Value bought | Value sold | Latest |
|---|---|---|---|---|---|---|---|
| Friedberg Ezra M | Director | 12 | 0 | 12 | — | $330K | October 2, 2026 |
| Pauls Matthew | Director | 10 | 0 | 5 | — | $54K | October 2, 2026 |
| Greenleaf Peter | Director | 5 | 0 | 5 | — | $54K | October 2, 2026 |
| Francis Knuettel II | CFO, Treas & Secty | 4 | 0 | 2 | — | $40K | May 22, 2026 |
| LIGAND PHARMACEUTICALS INC | Director | 3 | 0 | 0 | — | — | December 17, 2025 |
| Davis Todd C | Chief Executive Officer | 2 | 2 | 0 | $1000K | — | June 11, 2026 |
| Malamut Richard | Director | 2 | 0 | 2 | — | $12K | April 2, 2026 |
| Einhorn Andrew J. | Director | 1 | 0 | 0 | — | — | December 23, 2025 |
What kind of transactions these are 7 Form 4 codes
| Code | Meaning | Rows | Shares | Value at reported prices |
|---|---|---|---|---|
| S | Open-market sale | 24 | 18,796 | $486K |
| A | Grant or award | 4 | 71,500 | — |
| M | Option exercise or conversion | 4 | 21,232 | — |
| D | Sale back to the company | 3 | 56,447 | — |
| P | Open-market purchase | 2 | 35,948 | $1000K |
| F | Shares withheld for tax | 1 | 144 | $3,889 |
| G | Gift | 1 | 9,542 | — |
What each code means: Form 4 transaction codes.
Insider transactions
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Pauls Matthew | Sell S | October 2, 2026 | October 6, 2026 | 4d | 786 | $21 | $17K | 10b5-1 plan | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | October 2, 2026 | October 6, 2026 | 4d | 558 | $21 | $12K | 10b5-1 plan | Form 4 ↗ | |
| Greenleaf Peter | Sell S | October 2, 2026 | October 6, 2026 | 4d | 797 | $21 | $17K | 10b5-1 plan | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | July 2, 2026 | July 7, 2026 | 5d | 24 | $27 | $656 | late10b5-1 plan | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | July 2, 2026 | July 7, 2026 | 5d | 534 | $26 | $14K | late10b5-1 plan | Form 4 ↗ | |
| Pauls Matthew | Sell S | July 2, 2026 | July 7, 2026 | 5d | 94 | $27 | $2,572 | late10b5-1 plan | Form 4 ↗ | |
| Pauls Matthew | Sell S | July 2, 2026 | July 7, 2026 | 5d | 692 | $26 | $18K | late10b5-1 plan | Form 4 ↗ | |
| Greenleaf Peter | Sell S | July 2, 2026 | July 7, 2026 | 5d | 85 | $27 | $2,318 | late10b5-1 plan | Form 4 ↗ | |
| Greenleaf Peter | Sell S | July 2, 2026 | July 7, 2026 | 5d | 712 | $26 | $19K | late10b5-1 plan | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | June 15, 2026 | June 17, 2026 | 2d | 59 | $28 | $1,648 | 10b5-1 plan | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | June 15, 2026 | June 17, 2026 | 2d | 224 | $27 | $6,076 | 10b5-1 plan | Form 4 ↗ | |
| Davis Todd C | Buy P | June 11, 2026 | June 15, 2026 | 4d | 503 | $29 | $14K | Form 4 ↗ | ||
| Davis Todd C | Buy P | June 11, 2026 | June 15, 2026 | 4d | 35,445 | $28 | $986K | Form 4 ↗ | ||
| Francis Knuettel II | Option / conversion D | May 22, 2026 | May 26, 2026 | 4d | 42,500 | — | — | derivative | Form 4 ↗ | |
| Francis Knuettel II | Other A | May 22, 2026 | May 26, 2026 | 4d | 59,500 | — | — | derivative | Form 4 ↗ | |
| Francis Knuettel II | Sell S | May 22, 2026 | May 26, 2026 | 4d | 1,500 | $27 | $40K | indirect | Form 4 ↗ | |
| Francis Knuettel II | Sell D | May 22, 2026 | May 26, 2026 | 4d | 13,947 | — | — | Form 4 ↗ | ||
| Friedberg Ezra M | Sell F | May 14, 2026 | May 18, 2026 | 4d | 144 | $27 | $3,889 | 10b5-1 plan | Form 4 ↗ | |
| Malamut Richard | Sell S | April 2, 2026 | April 6, 2026 | 4d | 280 | $21 | $5,981 | 10b5-1 plan | Form 4 ↗ | |
| Malamut Richard | Sell S | April 2, 2026 | April 6, 2026 | 4d | 310 | $21 | $6,359 | 10b5-1 plan | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | April 2, 2026 | April 6, 2026 | 4d | 265 | $21 | $5,661 | 10b5-1 plan | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | April 2, 2026 | April 6, 2026 | 4d | 293 | $21 | $6,010 | 10b5-1 plan | Form 4 ↗ | |
| Pauls Matthew | Sell S | April 2, 2026 | April 6, 2026 | 4d | 371 | $21 | $7,926 | 10b5-1 plan | Form 4 ↗ | |
| Pauls Matthew | Sell S | April 2, 2026 | April 6, 2026 | 4d | 415 | $21 | $8,514 | 10b5-1 plan | Form 4 ↗ | |
| Greenleaf Peter | Sell S | April 2, 2026 | April 6, 2026 | 4d | 377 | $21 | $8,053 | 10b5-1 plan | Form 4 ↗ | |
| Greenleaf Peter | Sell S | April 2, 2026 | April 6, 2026 | 4d | 420 | $21 | $8,616 | 10b5-1 plan | Form 4 ↗ | |
| Einhorn Andrew J. | Other A | December 23, 2025 | December 29, 2025 | 6d | 12,000 | — | — | late | Form 4 ↗ | |
| LIGAND PHARMACEUTICALS INC | Other A | December 17, 2025 | December 19, 2025 | 2d | — | — | — | derivative | Form 4 ↗ | |
| LIGAND PHARMACEUTICALS INC | Option / conversion D | December 17, 2025 | December 19, 2025 | 2d | — | — | — | derivative | Form 4 ↗ | |
| Pauls Matthew | Option / conversion M | October 2, 2025 | December 12, 2025 | 71d | 2,123 | — | — | latederivative | Form 4 ↗ | |
| Pauls Matthew | Option / conversion M | July 2, 2025 | December 12, 2025 | 163d | 8,493 | — | — | latederivative | Form 4 ↗ | |
| Pauls Matthew | Other G | December 10, 2025 | December 12, 2025 | 2d | 9,542 | — | — | Form 4 ↗ | ||
| Pauls Matthew | Option / conversion M | October 2, 2025 | December 12, 2025 | 71d | 2,123 | — | — | late | Form 4 ↗ | |
| Pauls Matthew | Option / conversion M | July 2, 2025 | December 12, 2025 | 163d | 8,493 | — | — | late | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | November 25, 2025 | November 26, 2025 | 1d | 2,000 | $28 | $56K | indirect | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | November 25, 2025 | November 26, 2025 | 1d | 1 | $29 | $29 | indirect | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | November 25, 2025 | November 26, 2025 | 1d | 2,000 | $28 | $56K | indirect | Form 4 ↗ | |
| Friedberg Ezra M | Sell S | November 25, 2025 | November 26, 2025 | 1d | 5,999 | $28 | $168K | indirect | Form 4 ↗ | |
| LIGAND PHARMACEUTICALS INC | Other A | November 6, 2025 | November 10, 2025 | 4d | — | $9,000,000 | — | derivative | Form 4 ↗ |
Congressional trades
No member of Congress has disclosed a trade in this ticker in the filings we have parsed.
Related stocks
Tickers traded by the same people who traded PTHS, by number of filers in common. It shows overlap in public filings and nothing else.
- LGND Ligand Pharmaceuticals Incorporated - Common Stock 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 19 | 39 | November 10, 2025 | October 6, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.